TAS-102 and how it differ from more familiar agents, such as 5-flourouracil, capecitabine and S-1

Howard S Hochster, MD of Yale Medical Center discusses TAS-102 and how it differ from more familiar agents, such as 5-flourouracil, capecitabine and S-1 at ASCO GI 2016